Navigation Links
New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
Date:9/21/2008

Patients show significant improvement through 2-year follow-up

MENLO PARK, Calif., Sept. 22 /PRNewswire/ -- Two multicenter studies published this week in Otolaryngology - Head and Neck Surgery confirm Balloon Sinuplasty(TM) technology is safe and effective when used by physicians to treat chronic sinusitis patients.

The foundation for those studies was a six-month clinical trial called CLEAR that began in 2005. It included 109 patients who had minimally invasive sinus surgery with the Balloon Sinuplasty(TM) technology. They participated in one-year and two-year follow-up studies which reported:

-- 92% functional patency at one-year follow-up.

-- At two-year follow-up, 85% of patients reported improvement in their

sinus symptoms. No patient's condition worsened.

-- Clinically and statistically significant improvements in patient

quality of life maintained at one and two year follow-up.

-- No serious adverse events observed at any time point throughout the

study.

Balloon Sinuplasty(TM) technology is used to restore normal sinus drainage by widening constricted sinus passages with specially designed catheters and balloons. The technology has been used to treat over 40,000 patients since receiving FDA clearance in 2005 and can be used alone or with standard surgical instrumentation.

The Center for Disease Control data reports sinusitis is among the most common illnesses in the U.S., affecting an estimated 37 million Americans and leading to 500,000 surgeries a year. Symptoms include repeated infections, headaches, facial pain, persistent congestion and unrelenting fatigue.

"The goal of sinus surgery is to open the sinuses so they can function normally, while preserving as much natural anatomy as possible. With Balloon Sinuplasty(TM) technology, we are able to accomplish that goal with our current approach in a true minimally invasive way, and give our patients the r
'/>"/>

SOURCE Acclarent, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
2. Most Cancer Treatment Studies Arent Published, Study Finds
3. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
4. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
5. Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
6. Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
7. Genmab Announces Upcoming Ofatumumab Studies
8. Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
9. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
10. Treatment Corrects Severe Insulin Imbalance in Animal Studies
11. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013  Sinovac Biotech Ltd. ... of biopharmaceutical products in China ... subsidiary company of Sinovac, obtained the Certificate of ... from the China State and Food Administration (CFDA) ... production plants, and its Changping filing and packaging ...
(Date:5/23/2013)... Inc. (Vanda) (NASDAQ: VNDA ) today announced that ... of the Year by the Tech Council of ... 25 th Annual Tech Awards Celebration held in ... the leaders and innovators in the technology and life science ... regions. "We are deeply honored to receive ...
(Date:5/23/2013)...  Haemonetics Corporation (NYSE: HAE ) announced today ... Development, will present at The Deutsche Bank 38 th ... on May 29, 2013 at 1:30pm Eastern time.  ... The public may access Mr. Lindop,s presentation live via webcast ... Haemonetics (NYSE: HAE ) is a global ...
Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... a leader in unified RIS/PACS, Avreo continues to reinvent ... at RSNA.  Version 7 represents an extensive platform change ... , All new modern design with focus on workflow ... support, including Windows®, Mac OS® X, Apple® iOS, and ...
... 2011  Attendees of this week,s Radiological Society of North ... to see the latest addition to FUJIFILM Medical Systems ... medical informatics solutions. Fujifilm,s Synapse ® PACS 4.0 ... further maximize the user experience and improve overall efficiency.  ...
Cached Medicine Technology:Avreo Previews Version 7 RIS/PACS at RSNA 2Fujifilm Demonstrates the Latest Advancements of Synapse® PACS at RSNA 2Fujifilm Demonstrates the Latest Advancements of Synapse® PACS at RSNA 3
(Date:5/25/2013)... 25, 2013 The report “Global ... Types, Functions, Applications, Ingredients, Shell Materials, Packaging, & ... global food encapsulation market with analysis and forecasting ... also identifies the driving and restraining factors for ... trends, opportunities, and challenges. The market is segmented ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Studies from ... who are carrying excessive weight and their inability to ... many, simply losing weight can naturally relieve many symptoms. ... that improvement in sleep quality was significantly associated with ... month study dated November 6th, 2012, researchers ...
(Date:5/25/2013)... City Center, FL (PRWEB) May 25, 2013 ... is one of many of the NALA’s businesses throughout the ... Craig Amshel chose to participate in the nationwide event as ... as a Lieutenant Colonel in the Army. He said, “I ... in the community I serve, but I live here too.” ...
(Date:5/25/2013)... Pradaxa lawsuits filed on behalf ... bleeding while using the blood thinner continue to mount in ... of Illinois, Bernstein Liebhard LLP reports. According to a ... had been filed in the litigation as of ... by the Court on May 15th. ( In Re: Pradaxa ...
(Date:5/25/2013)... May 25, 2013 By working diligently ... declared the integration of the 2012 Lamborghini Aventador into ... the latest entrant in the list of vehicles lined ... vehicle is all set to thrill automobile lovers in ... power and spectacular looks, the 2012 Lamborghini Aventador comes ...
Breaking Medicine News(10 mins):Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2
... November is both Pancreatic Cancer Awareness Month and ... (NYBC) and its divisions in Manhattan, Long Island, Hudson ... community to join the fight against cancer by donating ... blood, and cancer patients may require frequent blood transfusions ...
... Daisy Martinez pleaded guilty today in U.S. District Court ... the Medicare program, Assistant Attorney General Lanny A. Breuer ... the Eastern District of Michigan; Andrew G. Arena, Special ... and Daniel R. Levinson, Inspector General of the Department ...
... the Melbourne Cup, Australia,s most prestigious and coveted horse race ... Melbourne Cup, and "Subbie" to several generations of Australian schoolchildren, ... quick actions of a "fairy godmother" from the United States, ... her pioneering efforts in the rice bran industry, flew to ...
... Ga., Oct. 30 CeloNova BioSciences today announced ... Notified Body a request for approval of its ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20081007/CLTU035-b ) ... Embozene(TM) Color-Advanced Microspheres are spherical embolics approved in ...
... while there are few new drugs in pipeline , ... antibiotic-resistant bacteria continues to present a major public health ... largest infectious diseases meetings Friday. , Chief among the ... to be infecting younger and otherwise healthier people. The ...
... ... insurers are denying discrimination against Swine Flu victims but when LSM Insurance recently called to ... ... not cover recent swine flu victims. Since July independent Canadian life insurance broker Lorne S. ...
Cached Medicine News:Health News:Community Blood Drives Benefit Cancer Patients 2Health News:Detroit Clinic Owner Pleads Guilty in Medicare Fraud Scheme 2Health News:Detroit Clinic Owner Pleads Guilty in Medicare Fraud Scheme 3Health News:Detroit Clinic Owner Pleads Guilty in Medicare Fraud Scheme 4Health News:Health of Subzero, 1992 Winner of Melbourne Cup, Threatened After Customs Mix Up 2Health News:Health of Subzero, 1992 Winner of Melbourne Cup, Threatened After Customs Mix Up 3Health News:CeloNova First to Produce Super-Sized Embolic Microsphere 2Health News:Antibiotic Resistance Still a Major Public Health Threat 2Health News:Antibiotic Resistance Still a Major Public Health Threat 3Health News:Antibiotic Resistance Still a Major Public Health Threat 4Health News:Life Insurance Firms Refusing to Insure Swine Flu Victims says major Canadian insurance broker 2
Full automatic, ready-to-use strip washer....
... Designed and manufactured ... the MultiWash II delivers ... you demand. The MultiWash ... with dependable accuracy, while ...
... 1983, Tosoh Corporation launched the first generation ... The HPLC/723Ghb brought a new level of ... the forefront of diabetes testing in Japan. ... generation system, the G7 offers advanced automation; ...
... CELL-DYN WorkCell delivers complete hematology automation to ... A modular configuration provides the flexibility to ... includes one Navigator module, one Load module, ... code reader. The basic system will incorporate ...
Medicine Products: